GSA Capital Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
GSA Capital Partners's EXAS Position: Q1 2026 in Review
GSA Capital Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,819 shares — an estimated $591K sold.
GSA Capital Partners first reported a position in EXAS in Q3 2014 and held it in 15 quarters. The position peaked at $1.46M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- GSA Capital Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 5,819 Exact Sciences shares in Q1 2026, an estimated $591K.
- GSA Capital Partners first reported a position in Exact Sciences in Q3 2014 and held it in 15 quarters.
- GSA Capital Partners's Exact Sciences position peaked at $1.46M in Q1 2019.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.